|
⚲
|
| Keyboard |
| In8Bio Inc | |
|---|---|
| Ticker | INAB |
| CIK # | 0001740279 |
| CUSIP | 45674E109 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 79 Madison Avenue, 2Nd Floor, New York, NY 10016 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| In8Bio Inc | 2025-12-30 | 20.1 M | Exemption: 506(b) · Remaining: $20,119,994 · Duration: One year or less · Commission: $1,207,200 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001740279] | 10-K | |
| [0001740279] | 10-Q | |
| [0001740279] | 3 | |
| [0001740279] | 4 | |
| [0001740279] | 8-K | |
| [0001740279] | D | |
| [0001740279] | SC 13D | |
| [0001740279] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Lytton Laurence W | In8Bio Inc | [2026-03-02] | 0.0 |
| Alyeska Investment Group LP | In8Bio Inc | [2026-02-17] | 0.0 |
| Franklin Resources Inc | In8Bio Inc | [2026-01-29] | 0.0 |
| Fairbairn Emily | In8Bio Inc | [2026-01-02] | 0.0 |
| 683 Capital Management LLC | In8Bio Inc | [2025-12-30] | 0.0 |
| Stonepine Capital Management LLC | In8Bio Inc | [2025-12-22] | 0.0 |
| Alyeska Investment Group LP | In8Bio Inc | [2025-02-14] | 0.0 |
| Hirschman Orin | In8Bio Inc | [2024-10-09] | 9.3 |
| Hirschman Orin | In8Bio Inc | [2023-12-15] | 9.4 |
| Transcend Partners Opportunity Fund I LLC | In8Bio Inc | [2023-08-11] | 13.0 |
| Ho William Tai-Wei | In8Bio Inc | [2023-08-11] | 0.1 |
| BIOS Fund II LP | In8Bio Inc | [2021-08-13] | 3.1 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
McCall Patrick
Employee Stock Option (right to buy) · derivative
|
2026-02-04 | Grant | 75,000 | $0.00 | |
|
Ho William Tai-Wei
Employee Stock Option (right to buy) · derivative
|
2026-02-04 | Grant | 206,000 | $0.00 | |
|
Lamb Lawrence
Employee Stock Option (right to buy) · derivative
|
2026-02-04 | Grant | 72,000 | $0.00 | |
|
Rochlin Kate
Employee Stock Option (right to buy) · derivative
|
2026-02-04 | Grant | 80,000 | $0.00 | |
|
McCall Patrick
Common Stock
|
2025-12-22 | Grant | 7,247 | $1.38 | 10,001 |
|
Ho William Tai-Wei
Common Stock
|
2025-12-22 | Grant | 36,232 | $1.38 | 50,000 |
|
Roemer Alan S
Common Stock
|
2025-12-22 | Grant | 36,232 | $1.38 | 50,000 |
|
Brandt Peter C
Common Stock
|
2025-12-22 | Grant | 72,464 | $1.38 | 100,000 |
|
Fairbairn Emily
Common Stock
|
2025-12-22 | Grant | 724,637 | $1.38 | 999,999 |
|
Rochlin Kate
Common Stock
|
2025-12-22 | Grant | 7,247 | $1.38 | 10,001 |
|
Greenwood Luba
Stock Option (right to buy) · derivative
|
2025-05-08 | Grant | 63,150 | $0.00 | |
|
Fairbairn Emily
Stock Option (right to buy) · derivative
|
2025-05-08 | Grant | 63,150 | $0.00 | |
|
Epperly Corinne
Stock Option (right to buy) · derivative
|
2025-05-08 | Grant | 63,150 | $0.00 | |
|
Brandt Peter C
Stock Option (right to buy) · derivative
|
2025-05-08 | Grant | 63,150 | $0.00 | |
|
Roemer Alan S
Stock Option (right to buy) · derivative
|
2025-05-08 | Grant | 63,150 | $0.00 | |
|
Graff Jeremy R
Stock Option (right to buy) · derivative
|
2025-05-08 | Grant | 63,150 | $0.00 | |
|
BIOS Fund II LP +8
Series B Warrant · derivative
|
2025-05-02 | Other | 574,241 | ||
|
BIOS Fund III QP LP +9
Series A Warrant · derivative
|
2025-05-02 | Other | 574,241 | ||
|
BIOS Fund III QP LP +9
Series B Warrant · derivative
|
2025-05-02 | Other | 574,241 | ||
|
BIOS Fund III QP LP +9
Pre-Funded Warrants · derivative
|
2025-05-02 | Buy | 1,148,482 | ||
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 19 | 3,752,794 |
| 2025-12-31 | 22 | 3,227,723 |
| 2025-09-30 | 19 | 980,319 |
| 2025-06-30 | 13 | 875,481 |
| 2025-03-31 | 29 | 21,678,562 |
| 2024-12-31 | 27 | 30,029,182 |
| 2024-09-30 | 27 | 7,625,802 |
| 2024-06-30 | 27 | 7,742,424 |
| 2024-03-31 | 33 | 8,640,550 |
| 2023-12-31 | 31 | 9,402,076 |
| 2023-09-30 | 22 | 2,476,931 |
| 2023-06-30 | 23 | 2,329,350 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares | Prev | Page 1 | Next |